CN113197985A - 一种能调理皮肤问题及皮肤软组织坏死的精油 - Google Patents
一种能调理皮肤问题及皮肤软组织坏死的精油 Download PDFInfo
- Publication number
- CN113197985A CN113197985A CN202110458589.XA CN202110458589A CN113197985A CN 113197985 A CN113197985 A CN 113197985A CN 202110458589 A CN202110458589 A CN 202110458589A CN 113197985 A CN113197985 A CN 113197985A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- essential oil
- soft tissue
- tissue necrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 70
- 206010065769 Soft tissue necrosis Diseases 0.000 title claims abstract description 27
- 230000005808 skin problem Effects 0.000 title claims abstract description 27
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 26
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 15
- 235000010804 Maranta arundinacea Nutrition 0.000 claims abstract description 15
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 15
- 235000012419 Thalia geniculata Nutrition 0.000 claims abstract description 15
- 241000934230 Anoectochilus roxburghii Species 0.000 claims abstract description 14
- 241001071917 Lithospermum Species 0.000 claims abstract description 14
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 14
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 14
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000746375 Andrographis Species 0.000 claims abstract description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 4
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 4
- 244000151018 Maranta arundinacea Species 0.000 claims abstract 4
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 4
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 4
- 239000000284 extract Substances 0.000 claims description 19
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 18
- 235000008397 ginger Nutrition 0.000 claims description 18
- 244000118350 Andrographis paniculata Species 0.000 claims description 11
- 241000382455 Angelica sinensis Species 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 241001506766 Xanthium Species 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000009210 therapy by ultrasound Methods 0.000 claims description 9
- 244000170916 Paeonia officinalis Species 0.000 claims description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 8
- 240000009022 Smilax rotundifolia Species 0.000 claims description 4
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 239000009670 cang er zi wan Substances 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 244000301850 Cupressus sempervirens Species 0.000 claims description 2
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 2
- 229940126678 chinese medicines Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 6
- 241000208340 Araliaceae Species 0.000 claims 5
- 239000001841 zingiber officinale Substances 0.000 claims 2
- 235000017008 Dioscorea nipponica Nutrition 0.000 abstract 1
- 241000908494 Dioscorea nipponica Species 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 31
- 230000002401 inhibitory effect Effects 0.000 description 26
- 230000001737 promoting effect Effects 0.000 description 19
- 230000006870 function Effects 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 240000004371 Panax ginseng Species 0.000 description 12
- 241000234314 Zingiber Species 0.000 description 12
- 241000193830 Bacillus <bacterium> Species 0.000 description 11
- 241000219304 Portulacaceae Species 0.000 description 11
- 244000145580 Thalia geniculata Species 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000002633 protecting effect Effects 0.000 description 10
- 244000132619 red sage Species 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 241001480043 Arthrodermataceae Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000037386 Typhoid Diseases 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000009194 climbing Effects 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 201000008297 typhoid fever Diseases 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001343277 Entada Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241001180873 Saposhnikovia divaricata Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001760 anti-analgesic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001595 contractor effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000037891 myocardial injury Diseases 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000003998 snake venom Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- HJRJRUMKQCMYDL-UHFFFAOYSA-N 1-chloro-2,4,6-trinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(Cl)C([N+]([O-])=O)=C1 HJRJRUMKQCMYDL-UHFFFAOYSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 241000563984 Ampelopsis Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 206010006242 Breast enlargement Diseases 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000834287 Cookeolus japonicus Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 241001299895 Microsporum ferrugineum Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 101000909851 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) cAMP/cGMP dual specificity phosphodiesterase Rv0805 Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000120647 Osbeckia Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000737257 Pteris <genus> Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241001617092 Tantilla gracilis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000001572 anti-trichomonad Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000000312 effect on influenza Effects 0.000 description 1
- 230000000001 effect on platelet aggregation Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003933 gonadotropin antagonist Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009284 tracheal contraction Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于精油领域,尤其是一种能调理皮肤问题及皮肤软组织坏死的精油,针对现有的精油功能性较差,不能满足人们的使用需求问题,现提出如下方案,其包括以下重量份的原料:当归5‑10份、金线草1‑5份、人参0.5‑1份、甘草1‑5份、箭根2‑6份、过山龙0.5‑1份、白鲜皮3‑7份、百部2‑6份、苍耳子4‑8份、苦参3‑9份、黄芩1‑4份、马齿苋0.5‑1份、穿心莲1‑6份、金银花2‑5份、柴胡5‑10份、丹参1‑5份、川芎2‑6份、紫草5‑10份、土茯苓3‑6份、地肤子1‑5份、防风5‑10份,本发明具有清热解毒,消炎、消肿、杀菌修复各种皮肤软组织,促使细胞生长,提高免疫力的作用。
Description
技术领域
本发明涉及精油领域,尤其涉及一种能调理皮肤问题及皮肤软组织坏死的精油。
背景技术
精油是指从香料植物或泌香动物中加工提取所得到的挥发性含香物质的总称。通常,精油是从植物的花、叶、根、种子、果实、树皮、树脂、木心等部位通过水蒸气蒸馏法、冷压榨法、脂吸法或溶剂萃取法提炼萃取的挥发性芳香物质。精油又分稀释的(复方精油)和未经稀释的(单方精油)比如仙人掌种子油。精油的挥发性很强,一旦接触空气就会很快挥发,所以精油必须用可以密封的深色瓶子储存。
现有的精油功能性较差,不能满足人们的使用需求,因此我们提出了一种能调理皮肤问题及皮肤软组织坏死的精油,用来解决上述问题。
发明内容
本发明的目的是为了解决现有技术中存在精油功能性较差,不能满足人们的使用需求的缺点,而提出的一种能调理皮肤问题及皮肤软组织坏死的精油。
本发明提出的一种能调理皮肤问题及皮肤软组织坏死的精油,包括以下重量份的原料:当归5-10份、金线草1-5份、人参0.5-1份、甘草1-5份、箭根2-6份、过山龙0.5-1份、白鲜皮3-7份、百部2-6份、苍耳子4-8份、苦参3-9份、黄芩1-4份、马齿苋0.5-1份、穿心莲1-6份、金银花2-5份、柴胡5-10份、丹参1-5份、川芎2-6份、紫草5-10份、土茯苓3-6份、地肤子1-5份、防风5-10份、赤芍1-5份、生姜基础精油30-50份。
优选的,包括以下重量份的原料:当归6-9份、金线草2-4份、人参0.6-0.9份、甘草2-4份、箭根3-5份、过山龙0.6-0.9份、白鲜皮4-6份、百部3-5份、苍耳子5-7份、苦参4-8份、黄芩2-3份、马齿苋0.6-0.9份、穿心莲2-5份、金银花3-4份、柴胡6-9份、丹参2-4份、川芎3-5份、紫草6-9份、土茯苓4-5份、地肤子2-4份、防风6-9份、赤芍2-4份、生姜基础精油32-48份。
优选的,包括以下重量份的原料:当归7份、金线草3份、人参0.7份、甘草3份、箭根4份、过山龙0.7份、白鲜皮5份、百部4份、苍耳子6份、苦参5份、黄芩2.5份、马齿苋0.7份、穿心莲4份、金银花3.5份、柴胡7份、丹参3份、川芎4份、紫草7份、土茯苓4.5份、地肤子3份、防风7份、赤芍3份、生姜基础精油40份。
优选的,其制备方法包括以下步骤:
S1、对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行处理,制得中药混合提取液;
S2、将中药混合提取液与生姜基础精油进行混合,制得混合精油;
S3、对混合精油进行超声处理,紫外灭菌,制得能调理皮肤问题及皮肤软组织坏死的精油。
优选的,所述S2中,将中药混合提取液与生姜基础精油进行混合,混合速度为300-400r/min,混合时间为30-60min。
优选的,所述S3中,对混合精油进行超声处理,紫外灭菌,超声处理时间为10-30min,紫外灭菌时间为20-40min,制得能调理皮肤问题及皮肤软组织坏死的精油。
优选的,所述S1中,对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行清洗,粉碎,提取,过滤,制得提取液,对提取液进行浓缩,制得中药混合提取液。
优选的,所述S2中,在进行混合时,中药混合提取液采用滴加的方式与生姜基础精油进行接触混合。
当归:有降低血小板聚集及抗血栓;促进造血系统功能;降血脂及抗动脉硬化;抗氧化和清除自由基;增强免疫系统功能;抑制I、Ⅱ、Ⅲ、Ⅳ型变态反应;对子宫具有兴奋及抑制的双向性作用;抑制前列腺增生;抗促性腺激素;抗辐射损伤;抗肿瘤;抗炎镇痛、抗损伤;保肝,利胆,促进消化,抑制胃肠的推动运动;具有抑制神经系统、松弛气管平滑肌、利尿、抑菌等作用。可抑制离体动物的子宫而兴奋整体动物的子宫。藁本内酯对实验动物有平喘作用,对其中枢神经系统有抑制作用。抗贫血作用可能与所含的维生素B12和铁、锌等微量元素有关。
金线草:具有排石、抗炎作用;对细胞免疫、体液免疫有抑制作用;能增强小鼠巨噬细胞的吞噬功能;对血管平滑肌有松弛作用,对试管内ADP及花生四烯酸诱导的人血小板聚集也有一定的抑制作用。水煎剂、注射液有利尿作用,给大鼠、犬和病人灌服或静注,均可见利胆、排石和预防胆结石生成作用。水煎剂、冲剂有抗菌和抗炎作用,对金黄色葡萄球菌有一定抑制作用;
人参:调节中枢神经系统的生理功能,提高机体免疫功能,强心、抗休克,保护和刺激骨髓的造血功能,增加肾上腺皮质激素分泌,调整血糖水平,显著抑制胆固醇的吸收,抗肿瘤,延缓衰老,加强机体的适应性,其提取物能明显促进大鼠器官核酸和蛋白质的合成;
甘草有肾上腺皮质激素作用,抗炎、抗溃疡、抗过敏反应,抗癌,抗菌,抗病毒,促进胰液分泌,对离体肠有抑制,调节免疫功能,镇咳祛痰,抗突变,解毒,抗氧化,保护耳前庭功能、利尿,保肝、防止动脉硬化,抗脑缺血,预防糖尿病并发症等作用;
箭根:以根条粗壮而长、色黄白者为佳。性味归经:甘、涩、平。归肝、肾经。功能主治:舒筋活络,强壮腰膝。治风湿骨痛,腰肌劳损,子足酸软,跌打扭伤等;
过山龙,又名羊葡萄蔓、草葡萄、茜草、地血、染绯、风车草(李时珍《本草纲目.草七.茜草》)。攀援藤本,长达12m,被褐色绒毛。叶片卵形或披针状卵形,长5—12cm,宽3—6cm,表面无毛,背面被密绒毛。头状花序较大,2-7个排成圆锥状;总苞片5层;花管状,紫色。瘦果有微毛,冠毛红褐色。花期11月至翌年2月。在我国大部分地区都有分布;
白鲜皮:对多种致病真菌具有抑制作用;能增强心肌收缩力,收缩血管;对子宫及肠平滑肌有强力的收缩作用;抑制免疫功能,尚具有一定的抗癌作用。水浸液对多种皮肤真菌均有不同程度的抑制作用;水浸液对温刺发热之兔有解热作用;对细胞免疫和体液免疫均有抑制作用,而不导致脾脏萎缩;
百部:能抗病原微生物;抗寄生虫;镇咳、祛痰、平喘;具有弱的抑制中枢作用;
苍耳子:抗微生物;降血糖;心率减慢,减弱心收缩力,扩张血管,增强血管通透性;抗凝血酶的作用,减少外周血中白细胞总数及可恢复胆固醇及甘油三酯至正常水平;抗炎镇痛;抑制细胞免疫和体液免疫功能;小剂量加强呼吸运动,大剂量抑制呼吸运动;抗氧化;抗癌;兴奋肠道等作用;
苦参:煎剂及其中所含苦参碱给家兔口服或注射,皆可产生利尿作用;煎剂在试管中高浓度对结核杆菌有抑制作用;煎剂、水浸液在体外对某些常见皮肤真菌有抑制作用;醇浸膏在体外有抗滴虫作用;
黄芩具有较广的抗菌谱,体外试验,对杆菌、球菌有抑制作用,对流感病毒、皮肤真菌亦有作用,临床用于治疗病毒性眼病及上呼吸道感染有较好疗效。动物试验表明,水煎剂具有抗炎、免疫促进和镇静解热作用;提取物有抑制HIV-1生长的作用。具有抗微生物、抗变态反应、降血压、利尿、降血脂、抗血小板聚集和抗凝、保肝、保护肾损伤的作用;低剂量促进免疫细胞增殖,高剂量则抑制;延缓白内障发生;
马齿苋:有收缩子宫的作用;影响心血管和呼吸系统;对骨骼肌呈双相作用,使小肠收缩张力、振幅和频率均增加,抗菌作用;具有降胆固醇作用。能促进上皮细胞功能的正常化及溃疡的愈合。有利尿作用。醇提取物或水煎剂对多种痢疾杆菌有显著抑制作用;还对大肠杆菌、伤寒杆菌、金黄色葡萄球菌及杜盎氏小芽孢癣菌等致病性皮肤真菌有抑制作用,对痢疾杆菌能产生耐药性;还能促进溃疡愈合、收缩血管、调血脂;
穿心莲:主要具有解热作用;多种穿心莲内酯及各种注射剂均有解热效果;还有抗病原微生物及抗炎、增强免疫功能;总黄酮体内体外能抑制ADP诱导的血小板聚集,抗异丙肾上腺素所致大鼠心肌损伤和对实验性心肌梗死兔有一定保护作用;另外,还有保肝利胆、抗肿瘤、抗蛇毒、抗生育作用。能明显抑制钙调素激活靶酶环核苷酸磷酸二酯酶的活性;对牛眼晶状体内醛糖还原酶有一定抑制作用;有抑制大肠杆菌的作用,且对大肠杆菌毒素引起的腹泻有对抗作用;
金银花:具有抗病原微生物、抗毒、抗炎、解热、促进炎细胞吞噬功能、降血脂、中枢兴奋、抗生育、预防胃溃疡、兴奋子宫作用。体外实验表明,金银花煎剂及醇浸液对金黄色葡萄球菌、白色葡萄球菌、溶血性链球菌、肺炎杆菌、脑膜炎双球菌、伤寒杆菌、副伤寒杆菌、大肠杆菌、痢疾杆菌、变形杆菌、百日咳杆菌、铜绿假单胞菌、结核杆菌、霍乱弧菌等多种革兰阳性和阴性菌均有一定的抑制作用。金银花的水煎剂、水浸液和提纯液,用平板打洞法,对致龋齿的变形链球菌,具有较好的杀灭和抑制作用,抑菌效果随浓度增大而明显增强;
柴胡具有抗炎、解热、镇静、镇痛、镇咳及抗惊厥作用;可减轻肝损伤和促进胆汁分泌;具有降血压、降低血清胆固醇以及溶血作用;具有抗溃疡、抗菌、抗病毒、抗肿瘤、升高血糖、降低血中脂肪含量、抗辐射损伤等作用;
丹参制剂能使实验动物心冠状动脉扩张,使心功能获得明显改善。注射液有抗凝血作用。提取物体外有抑菌作用。隐丹参酮是抗菌的有效成分。保护心脑系统;降血脂;抗动脉粥样硬化;活血化瘀;增强耐缺氧能力;增强免疫功能;抗炎及抗过敏;护肝;抗胃溃疡;抗肿瘤;镇静镇痛;对呼吸系统有保护作用;改善肾功能;抗氧化;抗菌;促进皮肤伤口、骨折愈合;
川芎对心脑血管系统的影响:对心脏有抑制作用;可扩血管,降血压;增加冠脉流量;对心肌及再灌注损伤有保护作用;改善微循环;改善脑循环及脑缺血。改善血液系统、利尿、增强免疫系统;可抑制白三烯、组胺、前列腺素E2引起的气管收缩;能预防和保护肾上腺素所致大鼠实验性肺水肿;有抗肿瘤及抗放射等作用;
紫草性味甘、咸,寒。归心、肝经。有凉血,活血,解毒透疹之功能。故对血热毒盛,麻疹、斑疹透发不畅等症,可与蝉衣、牛蒡子、连翘、荆芥等配伍应用;如疹出而色甚深,呈紫暗色而不红活者,这也是血热毒盛的症候,须以凉血解毒药如丹皮、赤芍、银花、连翘等同用;
土茯苓水提物在抗原致敏及攻击后给药均明显地抑制了三硝基氯苯所致的小鼠接触性皮炎,以攻击后给药作用较强。具抗菌作用。此外,对移植性肿瘤艾氏腹水癌和对黄曲霉素B,(AFB)致大鼠肝癌病变均有一定抑制作用;
地肤子1:3水浸剂试管内对许兰氏癣菌、奥杜盎氏小芽孢癣菌、铁锈色小芽孢癣菌、羊毛状小芽孢癣菌、星形奴卡氏菌等真菌都有一定的抑制作用,50%煎剂还对伤寒杆菌有较弱抑制作用;水提液有抗炎、利尿、免疫抑制等药理作用;水煎剂有抗炎、利尿、免疫抑制作用;
防风(Saposhnikovia divaricata(Trucz.)Schischk.)多年生草本,根粗壮,细长圆柱形,淡黄棕色。茎单生,自基部分枝较多,与主茎近于等长,有细棱,基生叶丛生,有扁长的叶柄,基部有宽叶鞘。叶片卵形,有柄。茎生叶与基生叶相似,但较小,顶生叶简化,有宽叶鞘。复伞形花序多数,生于茎和分枝,顶端花序梗长2-5厘米;伞辐无毛;小伞形花序有花4-10;无总苞片;小总苞片线形,先端长约3毫米,萼齿短三角形;花瓣倒卵形,白色,无毛。双悬果狭圆形,幼时有疣状突起,成熟时渐平滑;花期8-9月,果期9-10月。
产中国黑龙江、吉林、辽宁、内蒙古、河北、宁夏、甘肃、陕西、山西、山东等省区。生长于草原、丘陵、多砾石山坡。根供药用,用于治感冒、头痛、周身关节痛、神经痛等症;
赤芍:抗血栓;抗血小板聚集;降血脂、抗动脉硬化;小剂量轻度抑制心脏,大剂量明显抑制心脏,并有传导阻滞作用,使冠脉流量增加及减少外周阻力;治疗和预防心脏功能降低。抗肿瘤;具有保肝、清除氧自由基、解除肠痉挛、抑菌等作用。有排钠作用。提取物在体外对肾上腺素、ADP、烙铁头蛇毒和花生烯酸诱导的血小板聚集均有明显抑制作用。水煎剂在体外对伤寒杆菌、痢疾杆菌、金黄色葡萄球菌、溶血性链球菌等有较强抑制作用。
本发明的有益效果是:
本发明具有清热解毒,消炎、消肿、杀菌修复各种皮肤软组织,促使细胞生长,提高免疫力具有非常好的作用,对各种皮肤病,湿疹、疱疹、湿疣、顽癣、脚气、青春痘、黑斑、中耳炎、鼻窦炎、水火烧伤、内外痔疮、蚊虫咬伤、各种妇科炎症、子宫糜烂、囊肿、乳腺增生、淋巴结肿、妊娠纹和丰胸效果都非常显著。
具体实施方式
下面结合具体实施例对本发明作进一步解说。
实施例一
本发明提出了一种能调理皮肤问题及皮肤软组织坏死的精油,包括以下重量份的原料:当归5份、金线草1份、人参0.5份、甘草1份、箭根2份、过山龙0.5份、白鲜皮3份、百部2份、苍耳子4份、苦参3份、黄芩1份、马齿苋0.5份、穿心莲1份、金银花2份、柴胡5份、丹参1份、川芎2份、紫草5份、土茯苓3份、地肤子1份、防风5份、赤芍1份、生姜基础精油30份;
其制备方法包括以下步骤:
S1、对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行清洗,粉碎,提取,过滤,制得提取液,对提取液进行浓缩,制得中药混合提取液;
S2、将中药混合提取液与生姜基础精油进行混合,混合速度为300r/min,混合时间为30min,制得混合精油;
S3、对混合精油进行超声处理,紫外灭菌,超声处理时间为10min,紫外灭菌时间为20min,制得能调理皮肤问题及皮肤软组织坏死的精油。
实施例二
本发明提出了一种能调理皮肤问题及皮肤软组织坏死的精油,包括以下重量份的原料:当归7份、金线草3份、人参0.7份、甘草3份、箭根4份、过山龙0.7份、白鲜皮5份、百部4份、苍耳子6份、苦参5份、黄芩2.5份、马齿苋0.7份、穿心莲4份、金银花3.5份、柴胡7份、丹参3份、川芎4份、紫草7份、土茯苓4.5份、地肤子3份、防风7份、赤芍3份、生姜基础精油40份;
其制备方法包括以下步骤:
S1、对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行清洗,粉碎,提取,过滤,制得提取液,对提取液进行浓缩,制得中药混合提取液;
S2、将中药混合提取液与生姜基础精油进行混合,混合速度为350r/min,混合时间为45min,制得混合精油;
S3、对混合精油进行超声处理,紫外灭菌,超声处理时间为20min,紫外灭菌时间为30min,制得能调理皮肤问题及皮肤软组织坏死的精油。
实施例三
本发明提出了一种能调理皮肤问题及皮肤软组织坏死的精油,包括以下重量份的原料:当归10份、金线草5份、人参1份、甘草5份、箭根6份、过山龙1份、白鲜皮7份、百部6份、苍耳子8份、苦参9份、黄芩4份、马齿苋1份、穿心莲6份、金银花5份、柴胡10份、丹参5份、川芎6份、紫草10份、土茯苓6份、地肤子5份、防风10份、赤芍5份、生姜基础精油50份;
其制备方法包括以下步骤:
S1、对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行清洗,粉碎,提取,过滤,制得提取液,对提取液进行浓缩,制得中药混合提取液;
S2、将中药混合提取液与生姜基础精油进行混合,混合速度为400r/min,混合时间为60min,制得混合精油;
S3、对混合精油进行超声处理,紫外灭菌,超声处理时间为30min,紫外灭菌时间为40min,制得能调理皮肤问题及皮肤软组织坏死的精油。
对实施例一至三制得的能调理皮肤问题及皮肤软组织坏死的精油,对比常规的精油,实验数据如下表所示:
由上述表格可知,本发明提出的能调理皮肤问题及皮肤软组织坏死的精油在清热解毒,消炎、消肿、杀菌,促使细胞生长,提高免疫力方面的性能具有明显提高,且实施二为最佳实施例。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (8)
1.一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,包括以下重量份的原料:当归5-10份、金线草1-5份、人参0.5-1份、甘草1-5份、箭根2-6份、过山龙0.5-1份、白鲜皮3-7份、百部2-6份、苍耳子4-8份、苦参3-9份、黄芩1-4份、马齿苋0.5-1份、穿心莲1-6份、金银花2-5份、柴胡5-10份、丹参1-5份、川芎2-6份、紫草5-10份、土茯苓3-6份、地肤子1-5份、防风5-10份、赤芍1-5份、生姜基础精油30-50份。
2.根据权利要求1所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,包括以下重量份的原料:当归6-9份、金线草2-4份、人参0.6-0.9份、甘草2-4份、箭根3-5份、过山龙0.6-0.9份、白鲜皮4-6份、百部3-5份、苍耳子5-7份、苦参4-8份、黄芩2-3份、马齿苋0.6-0.9份、穿心莲2-5份、金银花3-4份、柴胡6-9份、丹参2-4份、川芎3-5份、紫草6-9份、土茯苓4-5份、地肤子2-4份、防风6-9份、赤芍2-4份、生姜基础精油32-48份。
3.根据权利要求1所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,包括以下重量份的原料:当归7份、金线草3份、人参0.7份、甘草3份、箭根4份、过山龙0.7份、白鲜皮5份、百部4份、苍耳子6份、苦参5份、黄芩2.5份、马齿苋0.7份、穿心莲4份、金银花3.5份、柴胡7份、丹参3份、川芎4份、紫草7份、土茯苓4.5份、地肤子3份、防风7份、赤芍3份、生姜基础精油40份。
4.根据权利要求1所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,其制备方法包括以下步骤:
S1、对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行处理,制得中药混合提取液;
S2、将中药混合提取液与生姜基础精油进行混合,制得混合精油;
S3、对混合精油进行超声处理,紫外灭菌,制得能调理皮肤问题及皮肤软组织坏死的精油。
5.根据权利要求4所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,所述S2中,将中药混合提取液与生姜基础精油进行混合,混合速度为300-400r/min,混合时间为30-60min。
6.根据权利要求4所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,所述S3中,对混合精油进行超声处理,紫外灭菌,超声处理时间为10-30min,紫外灭菌时间为20-40min,制得能调理皮肤问题及皮肤软组织坏死的精油。
7.根据权利要求4所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,所述S1中,对当归、金线草、人参、甘草、箭根、过山龙、白鲜皮、百部、苍耳子、苦参、黄芩、马齿苋、穿心莲、金银花、柴胡、丹参、川芎、紫草、土茯苓、地肤子、防风、赤芍进行清洗,粉碎,提取,过滤,制得提取液,对提取液进行浓缩,制得中药混合提取液。
8.根据权利要求4所述的一种能调理皮肤问题及皮肤软组织坏死的精油,其特征在于,所述S2中,在进行混合时,中药混合提取液采用滴加的方式与生姜基础精油进行接触混合。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110458589.XA CN113197985A (zh) | 2021-04-27 | 2021-04-27 | 一种能调理皮肤问题及皮肤软组织坏死的精油 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110458589.XA CN113197985A (zh) | 2021-04-27 | 2021-04-27 | 一种能调理皮肤问题及皮肤软组织坏死的精油 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113197985A true CN113197985A (zh) | 2021-08-03 |
Family
ID=77028926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110458589.XA Withdrawn CN113197985A (zh) | 2021-04-27 | 2021-04-27 | 一种能调理皮肤问题及皮肤软组织坏死的精油 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113197985A (zh) |
-
2021
- 2021-04-27 CN CN202110458589.XA patent/CN113197985A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178809B (zh) | 一种清热解毒消肿和活血止疼生肌的皮肤外用药物及其加工成药剂的方法 | |
CN103520607B (zh) | 一种治疗胃炎的中药制剂 | |
CN103202880B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN113876688A (zh) | 抑菌养护洗液及其制备方法 | |
CN113197985A (zh) | 一种能调理皮肤问题及皮肤软组织坏死的精油 | |
CN107638478B (zh) | 治疗皮肤病的瑶医外用制剂及其制备方法 | |
CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
CN113318158A (zh) | 一种用于治疗鼻炎的外用组合物及其制备方法 | |
CN105561098A (zh) | 一种治疗糜烂性脚气的药物 | |
CN105456957A (zh) | 一种治疗狐臭的中药组合物 | |
CN111632080A (zh) | 一种治疗药疹皮炎的配方及制备方法及应用 | |
CN115998828B (zh) | 一种治疗乳腺增生的中药组合物及其制备方法 | |
CN114344434B (zh) | 一种治疗肺结节的中药组合物及其制备方法 | |
CN116270830B (zh) | 一种抗辐射的中药组合物及其应用 | |
CN108714167B (zh) | 一种治疗白癜风的中药外用制剂及其制备方法 | |
CN105663429A (zh) | 一种治疗水泡型脚气的药物 | |
CN110721302A (zh) | 一种消炎镇痛组合物及其应用 | |
CN111789891A (zh) | 一种治疗湿疹的中药软膏的制备方法和应用 | |
CN105169277A (zh) | 一种保肝利胆的栀子口服液及其制备方法 | |
CN104666468A (zh) | 一种治疗甲亢、淋巴结核的药物组合物 | |
CN116173116A (zh) | 用于清热泻火的中药组合物、中药提取物及其制备方法 | |
CN114010745A (zh) | 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 | |
CN114939143A (zh) | 一种治疗肠癌手术后便秘的脐贴剂和口服制剂 | |
CN113769041A (zh) | 一种用于治疗妇科炎症的外用中药组合物及其制备方法 | |
CN117599124A (zh) | 一种治疗荨麻疹的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210803 |
|
WW01 | Invention patent application withdrawn after publication |